Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014)

The linezolid experience and accurate determination of resistance (LEADER) surveillance program has monitored linezolid activity, spectrum, and resistance since 2004. In 2014, a total of 6,865 Gram-positive pathogens from 60 medical centers from 36 states were submitted. The organism groups evaluate...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Flamm, Robert K., Mendes, Rodrigo E., Hogan, Patricia A., Streit, Jennifer M., Ross, James E., Jones, Ronald N.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2016
Témata:
Epidemiology and Surveillance
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4808230/
https://ncbi.nlm.nih.gov/pubmed/26833165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02803-15
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky